








rhc:dcvatc:d pIllS maze rc:wakd IhatCavl.2DIIP-I-haddiITcrc:nt basclinc:all:xiC:lykvcls
comparc:dtowildtypcrnice, Nicotine wasanxiolytic aClItdy (lollo\\ingont:Jayoflrc:atIllCIll)in
Ca, 1.2011 P-I- mice. while in wi Idtype mice repentcd nicoline was st:en to induct: ~lIl:xiolylic






prelre3lment in Cuv I.2DHP-I-and wildlype(which blocked bolh Cuvl.2 and Cavl.3)micc
<lbolishcdthccondilionnlprefcrencefornicOline.suggcslingC"vl.Jlllcdi3lcdnicolinic
prefcrcnce,llowc"cr.whcnCav l.3-I-micewerclcslcdfornicotincprefercnce.thcircondilioned
place preference was similar to Ihat in wildlypeand Cavl.2DHP-I-mice. Flirtherwork is needed
lounderslandlhcdifTcrcnli<llinvolvcmenlofthcsesubtypcsinnicolinc-induccdplnce
Inconclusiollourrcsll!lsindicaIClhatlheL_lypccalcilimchannc! sllbtypc Cuvl.2 may be
morcilctivclyinvolvcdinanxicty,whilcCuvl.J,whcnprcscnt.appears to bc more critical in
inducing nicotinc prclcrcl1cc. Faillircloconlirmthislindingi n C,:lvl,3·I-rnicc may bcdue to
compcllsatorychangcsillotherL-typesubtypesorredundnntrcwardcircuitry
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3.4 i\ sing II: nill.:dipinl: prl:trcatment decn:as~d nicotinl: illdllc~d I:xploration in Ca, 1.2DllP-
3.5 Nili:dipineincrcascdunxiolylicefli:ctsinrl:jX":ih:dnicOlinl:tn:ntl'dWT




nicoline plnee preference. which prctreatment with nifcdipine wnsablc to




vital in nicoline nddiclion. overall addiction and Ihe mesolimbic VTAdopaminergic




Figure I: Ca~ 1.2DIIP-I- mice g~not)'pillg results
Figure 2: Ca~I.3-1- mic~ g~not)'ping rcsuhs
Figure 3: Cn~ 1.201IP-I. nnd WT mice groups show ~xpectcd ]0010 open <trill time for a single
Figure4:NonnnlizedopennrmtimeforCav l.2DI-IP-I-andWTmiccshowed nnxiol)'tic cnccts
followingnsingle injection of nicotine inCav l.2DI-IP-I-micc
Figurc5:SingleandrepeatednicotinetrcatmcntinCav l.2DIII)_I_andWTmiccrcspecti\'cly.
Figure 6: Rcpcated trcatmcnl. but not a single dose of nicotine. incrcnscdopcnannentriesinWT
Figure 7: Unprotecled stretch attends show a decrease in ~U1xiety following both singlc and
Figmc8: Protected stretchnttcnds increase both following single nndrepcatednicotinedoscs.
Figure 9: A single dose of nicotine led 10 Ca~ 1.2DI-IP-I- mice displaying a higher unprotectcd
Figure 10: Protcctcd head dips arc dccrcased in WTlllicctrcatcdwilhnilcdipine.whichhaslhe
Figure II: Repeatcd nicotine treatment is anxiolytic in WT but not Ca~ 1.2DIIP-I-
FigureI2:WTnilcdipinctre<ltcdmicehavcincrcascdopcnarmlimefollowingrcpeatcdbutllot
Figur~ 13: WT nili:dipine trl'a1~d mic~ show an incrcase in open ann entrics lollo\\ing repcalcd
Figur~ 14: J icotine place preference was seen in all three genotypes ofmici:
Figuri:15:Nifcdipincbloch-dnicotinc'sabilitytoc:lllscaplacl:prcfcrcnceinWTand
Figure 16: Slllllmary grnph showing how chronic nicotincl:stabJishcsa place prcfercnci: and how
Chapter I
1.1.1. Nicotinc,isithighlyaddictivc'!
Addiction has bccn classified as a chronic illness. consislingofrcpcatcddruguscinspilc
ofbolhlhchcalthrisksandsocialcollscqucnces.ltisdefillcdbycol11pulsivc drug seeking in
ordcrloinducClhepositivesymplomsandtoallcvintca\'crsivcwilhdmwalsymptolllsbroughton
bylhcdrllgbcillgdcplctcd in lheir syslcm (Chen el al.. 2009; Nichaus,Cruz-Bt.:rmudczctal
2009). Drugs of abuse. along with nalural rewardsslIchas rood and water. arc knowll 10 havc lhc
S<lmc nCllrOlll1alOmical substralC, the mesolimbic dopuminc (DA) pathwaycolllrnonlyrcfcrn:dto
astbcbrninrcwardpathwuy.l-lowcver,thcdiffcrcncebctwccllthcl\Voislhatdrugsofabusc
ovcr-stirnlliutc Ihc circuitry callsing lasting changes leading tocr<lvings.compulsivcdrllgsceking
and rclupsc (Niehaus. Cruz-Ocrmudczcl al. 2009). NicotinclisciSOl1corthemostcollllllon
forms of drug addiction. duc 10 both its legal availubility and st rongliddictivcproperties.Sowhy




inlOf.:OI1H.'Xt.only malaria kills 1ll0rc people worldwide (Pil:rcc andKlIlll.:lrl:s..1n2006).Oncmllsl
bear in mind. ho\\cvcr. that some of the heal th risks related 10 nicotinc .:lbusr: ~lrc dr:riVl'd from
thc acccssory compounds included in cigart.:llcsandothcrlobacco products.E\t.:nha\inga
gt.:nllincdcsirc 10 cease sll1okingdocs 1101 guaranl(.'e SllCCCSS. as 80010 ofsll1okers who quit rdapsl:
\\ilhin Ihcir tirsl year oFquining (Biala and Dudzynska2006: Di ""I altco. I)icnlccidal. 2007).
icotinein its nalurally-occurringslate isan alkaloid prcscnl intob.1CcO Iea\'es. which
aClsasanillsecticidcFortheplanLSincenicotincinilsnalurnlstatcisawcakbase.ildocsnol
havc lhcabiJily 10 cross ccllular membrancs easily. In ordt.:r 10 bc rap idlyabsorbcdiniotheilings.
nicOlinc is smoked. c311sing il to be ionized. allowing rupid croSSillgintolhcalvcoJitDenowitz.
Illlkk:mcnClal. 2(09). This Illethod whichdcliversnicolillCIOlheccntralllervolissyslcm(CNS)
approximalclyl0-20sccondsanersllloking is lllllCh qllicker lhan an intrllVCl101lS injcclion. Of all
l1lClhods by which nicotine is dclivcred. cigarcttc smoking raises Ihc nicotine blood
conccntrlliionthe raslcst(Diala2003; Dialaand Dudzynska2006: I3cnowitz.Ilukkanenctal
2009). whidl logically explains why abuscofnicotinc pl'ill1:ll'il yocclirsthroughsll1oking.Thc
:lmountofnicOlincabsorbcdfromcigarettcslllokingisapproximatclyl.l.5mg(llenowitz.
IlukkallcnctaI.2009). which isslighllyhighcrthanlhcdoscgiven in ll10stnicolinc·rclatcd
anilllalr:xpcrill1cnlS: howcvcr. thcdosc used in animals is rdativc to lhcirbody wcighl and brain
size (Gmbus. Marlin ct a!. 2006: KOla. Martin ct al. 2007: Portugal~lIldGollld2009)





fromll1icrodiaIYSUlcapplicalionofnicotillC\\hichincrcasedDArclcase in lhc lllldcliS
accumbens( Ac)(Mifsud.HemandezetaI.1989).\\hilcYoshidaclal.(1993)shO\\Cdlhallhe
DA incrcase was dicitcd primarilythroughnicotillcapplication in IhcVTA(Yoshida.Yokooct
Nicoline binding nOI only cxcitcs DA nt::uronsblll il is also caliSCS ndnpli\'c changes lOY,
nminoblilyric acid (GABA) neurons and glulamate andGABA tcrminalsinthcVTA.Upon
applicatiol1ofnicolincwithinthcVTA.GABAncuronswcrcshownto firsl incrcascfiring.
howcvcr nicotinic ncctylcholine reccptors(nAChRs)onGABA terminl.lls desensitize quickly
allowing DA cclls to bedisinhibited (Mansveldcr. Kcnlh cl <lJ. 2002:DiManco,Picruccietal
2007: Nichaus. Cruz·lkrmudezetnl. 2009). DisinhibiliollofOl\ncurOliS allows cilhcr Ii ring to
occur ill thc lirsl place or tocolltinllc for an cXlcnded period oftirnc.llowcver.nI\ChRsloealcd
on gllitall1atc tcrlllinalsdo not respond in thes<lrne man ncr as lhosc on GA13A terminals: these





VTAdopamincccllshavcbt.-cnamajorfocusinaddictionrcscarch.rhcy arc small to
lllcdilllllsizcdncurons, v':Iryinginovcrallshapc(c.g.somcarc fusilo rm) and me gcncrallysccn
inlhehorizonlalplanc($wnnsonI982).DAcrgicnclironscanbcidcntificdlhrough
iml11unocylochcmical\islializ.1Iionoflhedopaminc·s)l1lhesizingcnz)l1lc.tyrosinch)drox)lasc





primarily produced in spike-IYpe firing, but DA neurons havc the ability tospontancously burst·
lirc,withmcmbrancpolcntia[soscillatingfrom-4olo-60mV(GraceandOnn 1989: Mucllcr




2007). DA neuron burst-firing has bccn shown 10 occur in vitro l'oll owingapplicmiol1of
glulamatcrgicorcholinergicstimullls.thcrcbycnllsingCa2>innux. This has also bcen shown 10
occlirinbchavingprimalcsill1ll1ediatelyrollowingpn:senlaliollofnovel or salicm Slill1uli. such
[)orcctaI.2007),Ochaviorallythclinkbl,,·lwccnburslliringscl,,·nil1\itroamllhaISCcninvi,'o




commitling il to memory (Grillncralld i\krcuri 2002)
1.1.3. Nicotinic Acetylcholine Receptors
Nicoline has bcen shown consistenllyto beoneoflhclllosiaddiclivcdrugs. and so
logicallyhavingthcirrcceplorsillhighconcentr<llionilllhcbrnin. in Illuhiplcarcils. Illay Icad 10
majormcsolimbic longtcrm changes. Thisassumplioll iscorrcclasnAChRsurc located not only
on DA and GAOA cell bodicsnnd terminals. but alsoglutamatc and GAI3Acrgiclcrminals




nicotinc.intonn inlraccllularsignal in the form Ofciltionic in llllX (l3arik and Wonnacott 2009)
nAChRsoscillUlcbctwccnfourstatcs.dcpcndingonwhclhcranagonistisprcsclltornoLDuring
lhcrcslingslalc.lhcchannclisclosedandthebindingsilcforlhcagonisl isnotoccllpicd. while
during thC:'IClivcstalc Ihcchanncl is open. Thcdcsensilizcd stalcoccursfollo\\inglhcacti\c
st:.ltc\\hcn the channel iscloscd. blll Iheagonist is still bound wil hhighallinity.\\hilcthclimll
Slall.: is il1al:livation. which isa long-lastingin:U:livaliollof Ih..:r.:hannd(l1arik:lI1JWonnncoll
nAChRsnrCCXlrcm..:lydivcrSl:andhctcrogl:llt.:uus.havingsixasublinils:l!ldthr..:cp
slibunilsinn..:urons.\\hich:ln:arrang..:dinJilrcrcnlcombinalions JcpcnJing 011 th..:ir loc:ltiull
(Lc Novl.'rl.'. GrUtlcrl.'1 al. 2002). \Vi thin lhe VTA. DAcclI bodil.'shnvca-laSf12.a7.a-la6aSp2.
\\hl:fl:asglulam:ueh.:nninnlshavca7.andGA13Acdlbodicshnvca-lp2aS nnda7. and a-lp2 on
GA13AnndDAIt.:nninals(Picciotlo200J:WonnncOlt.SidhpufilclaI.200S:Pi..:rccnnd
Klimarcs..'ln 2006). Thc import..'lnceofdilTcrcnl nAChRs has bccn dcmonstratl.'dthrollgh
1IIiliwlionoftr.l!lsgcnicmolisemodclslackingindividualnAChRslibunits. In Yangelal.(2009)
IheyassertcdthaillAChRsinwhichlhep2subunilwasprcscntappcarcd 10 bccrucial for
nicotincreinlorccment(Ynng. Huclnl. 2(09).Micclackinglhcp2sllbunit wcrcshowll 10 have
:ltIcmlaK-dnicotincsclf-adminislralioll.nlongwilhdccrcascdVTADAaclivily(Picrccand
Kumaresnn2006).AnuprcgulalionloJlowingchronicnicolincabllSCissecll illnAChR subtype
a4p2.whichll1irrorswhal is sccn in long-term hllmnn slllokcrs(Dam,ti 2005:\VollllnCOtl.
Sidhpuract al. 2005). ThcsecxpcrimentsshowthatnAChRsublype spccificilY is imporlmlt. as
it allowsdilli.:rent sublypcs 10 bellprcgulatcd lollowingrcpcatcdagonistapplic:ttioll.whilcothcl
sllblypCs.suchasinmllsclcs.rcmainunchangcd
It has bCCll shownthnt IhcVTA is crucial in prodllcingan incrcascinDArcleasc.Fllct
al.(2000)dcmonstratcd Ihisby infusing nicoline antagonisls in10 both lhc VTA and NAc
prodlicingagrcatcrinhibilionofnicotine-indllccdDArclcasclhan ironJythc Nf\C wns blocked.
indic:llinglh..:VTAiscrilicalinlhcaddiclionpmhway(Fll.ManactaI.2000).lnaddition.
nAChRs also bolh direclly and indireclly activate Cn2•channels c~lUsing local dcpolariz:ltion of
the DA ncuron (Wollnacon. Sidhpllraelal. 2005). NicolineaCli\:llion ofnAChRsmediatcsCa1 '
entry inlo DA neurons. callsingacli\atiull of protein kill~lse;"'\ (PKM). inducingburst-liring
(Lhang.LilietaI.2005).along\\ithaetivatingtheci·CaM-depcndClllealcineurinpallmay
(Rnjadhyal..shaandKosofsky2005).ActivationofnAChRsstimulmcscalcium through processes
such as: gllltmn:lIC nctivation ofN-methyl-D-asparlic acid (N~·IDA) rcceplors lhat release
calciullllhroughvohnge-gatcdcalciulllchanndsfollo\\ingdepolarizationbynAChRs:alldc\,\.'1l
nAChRs thcmsclvcsare pcrmeablc to calcillm (Zlmng. Lillcl al. 1005). Rescarchfromollrlab
sho\\i,.'d thalcholincrgic.blll not glutamntcrgic aClivalion.allcrsCaz·channcls.spccificall)
LTCCandmediatesanincrcaseinfiringofDAergicncurons(LiunndChen 2008). This led to
IhehypothcsisthntifLTCCareessenlialinVTADAtiring.lhcnthcymay bc vilal to the
bchavioralrcpcrclissionsofnicOlineaddiclion.slIchasanxiety.incrcascdactivilylcvcland
rhcimportanccofCa2+inlheconlrolorDAncuronfirillghasbccnprcviolls\yshownin
Ollr lab in cxpcrimcl1ts in which carbachoL acholillcrgic agonist . was shown to indllccbllrsting
ill DA nClironsrnainlybyCaz+cntrythrollgh LTCC(Zhang. Lillclal. 2005). 13llrsl liring is
advanlagcolisasilcnablcshighcrDAtransmissiondllCloannccumulatiollOrCa2+inthc
tcrlllinal.fncilitatingDArclcasc.causcdbysalurntiol1ofDArcuplakctransportcrsandlhe
n:ductionol'alllorcceplor inhibition allowing agreaterconccntnnionofDA at the synapse
(GononI988:Liu.DorcctaI.2007).Thcretorc.ifburstingincrcasc:sDArdcascfromlhcVTA









cell somasanddendrilcs.pJayavilal role in calcium dcpendcnt gCllc Iffinscriplion(HclJ
WcstenbrocketaI.1993:]-Ictzcnalicr.Sinneggcr-BrallnsctaI.2006). which is key in rcinforcing
addiction and rcward (Giordano. Satputcclal. 2006)
LTCCshavc foursubtypcs.Cavl.I.Ca,.1.2.Ca,.1.3andCavl.4(Stricssnig.Kosch<lkctal
2006:StricssnigandKoschak2008),whichhavcthrccmainsubllllits (al. Cl2-oand j3)anday
sllblinitprcsentintheCavl.lsllblype(RajadhyakshaandKosofsky2005:Slricssnigand
Koschak 2008). Theal subunit is the pore lonllingsllbllnit. which 0 pcnsfollowingmembrane
depolarization. rhcdrllgbindingdomain tor modllintors ofLTCCs is Joc:ltcd"'ithinthcCtI
subunit(C1ark.Nuganocta1.2003:llctzcnalicr.Sinncggcr-lJraunsctaI.2006:Stricssnigand
Kosch:lk 2008). The flando2-&subllnils.althollgh not pore lorming.meimportallltorchanncl
targt:ting to tht: plaSlll~1 Jllt:Jllbrallt:. along with imlividllalizing gating properties or lh~ CLI subunit
(Stril.'ssnig :lI1d Kosehak 2008). L-typ~ Ca1~ channels operalt: in Ilm:c gating forms: an
inar.:tiviltioll moll~ in \\hich channels arc Ilot atlibcrly to open t:\'t:n \\ilh dcpol:nizalion: a short
opening form thai oct:lIrs followingdcpobriz<llionandilnalurallyoccurringlongopenrorm
1.2.2.L-typccalciultlchannclsandnicOlincaddiclioli
LTCCs havebccll studied in relation loaddiclionand mCl11aldisordcrs.specilicallyin
how they til ilHolhcmcsolimbicrewardpmhway. Nicoline has Ix.OCl1 sho\'vn 10 indllcc a strong
place prdercncc. atcsl that measllrcsthe reinforcing properlics ol' drllgsandfollowing
prclrealmt.:nt with an LTCC anlagonisl (nifedipinc) nicotine placcprcfcrencewasprcventcdfrom
occllrring(lliala2003:BialaandBudzynska2006)
llehavioraJworkusingthedcvatcdpJusmllzc(EPM)hasshownaclitc(single dose)
nicotinc 10 be anxiogcnic. while repcated nicotine is shown 10 be anxiolytic in micc. Prctrcatm~nt
wilha LTCCanlagonisl was shown to block bOlhshorHeflll anxiogenicnieotin~dfecls.arong
withto[cram.:cfromrcpeatcduscandanxio[yliedTccts(BialamldBudzynsku2006).Thc
involvement ofLTCCs is by no means uniquc to nicotinc: therc is ~vidcncc thallhcse channels
areimpJicntcdinthcnetionsofotherlypesofdrugsofnbusc.RcpcalcdinjectionsofthcLTCC
aetivatorl1ayK 86...4 inlothc VTA was shown 10 enusc behavioral sensiti/ation. through a non·
spccificcxciwlionofcellsinlheVTA.whilcthcglutamalcagonistNMDAhasllocOeel(Licata.
FreclIlanctl.ll. 2000). showing Ihat LTCCsindependcnlly play acritieal role in thcrc\\ard
eircuitry.LTCCsarckno\\lltomodlilalcDAcdlsynapticaClivity.Ca!'rdcascfromilllcrnal
stor~s and to tH.:tival~ Cal> dcpendcnt kill:lses. rhey also activutc K' channels lucttlcd otllhc
plaSlllllmcmbranc(Lill.Don:claI.2oo7):llldplayarolcin long-lcrmpotcntiation(LrP)
(Fourcaudol. G;:lmbinoCI al. 2009: McKinlley. SzcclaJ. 2009)
DcspilelheimportnnceofLTCCsubt)pcsCa"I.2andCa,I.J.lhcyarepharmacologically
indistinguishablcandlhcrcforcneilherl',mbclargcledindividual1y.DcspilcreportslhatQ-
;:1I11ino.J.h)'droxyl-5-nlt=lh)'I.4.isoxazole.proprionale(A~WA)and N~IDA receptors pla)'a kt:y
role in exciting DA neurons wilhin the VTA{Licala. Frecman clal. 2OOO),our lab has prcviollsly
burst.firingin DA nClirons, showinglhal LTCC induces bursling indepcndclltofgllllamalc
tmnsmission {Liu, Doreel al. 2007). LTCCantagollisls, sllch as 01 Il' modlilators. havebcen
showll 10 prc\'\.'nt firing in dopamine neurons (Grillncr and Mcrcuri 2002)
LTCCsublypcaclivnlion leads 10 burst firing and lhcrcforcmaybckcyinaddiclion
initial ion and rcinforCClllcnt. indicating investigation bolh in vitro and bchaviorally is rcquircd
Ilowcvcr,wilholltbcingabletodistinguishbelwccnLTCCSllblYPCs,lrcalmentoptionsfor












2004). Calcilllllcniry through neuronal LTCCsallcctncuronal fllnct ion by turning on gene
Iranscriptionwithinlhcnllclclls(Dolmctsch.PajvanictaI.2001).asthcyarcsituatcdon
proximaldcndritcsandtheccllbodicsofneurons(llell.\VeslenbroekClat.I993),alollgwith
activating a cascade leading 10 burst firing of dopamine neurons inthcVTA(LiunndChcn









Naganoct al. 2003; Stricssnig. Koschaketal. 2006). ThissublYpe isalsolocalcdinncuronsof
IhcCNS. cndocrineeclls'lIld cochlear hair cells. Mieedcficicntof LTCCsubtypcCa,I.3arc
dcaLdllC to the complcte abscncc of this sllbtypc witbin the inner andolltcrcochlcllrlwircclls
(Ptatlcr. Engdetal. 2000). Dcspitcallthcsedclicicncics.Cll\,1.3 (./.) mice do not show any
gross anatomical or motor fllnclion irnpairmcnls(Platzl:r. Engd cla1.2000)
Onc interesting tindingol'theStricssniggroupislbat mice lack ingtheCav l.3s11btype
display an antidepressant· and anxiolylic·like behavior. which implicutcs Ca~ 1.3 in playing a
rnajorrolc in disordcrsslich as addiction. merllal illnesses (depression)nndwithdra\\alfrorn
drugs(Stricssnig.KoschaketaI.2006;lJllsqUcI,Khoifguyc..:nctaI.2009).TheCa¥I.3LTCC
subtypeactivalcs:ll·50mV. \"hich isa lower rnembranc potential Ihan Ca,I.2 (Xu and
Lipscorubc2001).Ca,1.3hasbecnsho\\1lIobepredominanIO\CrCa.. 1.2inpCREI3 signaling in
hippocampus neurons \\ ben stimulated at low intensities (1.Iwng. Fu cI al. 2006). \\ hich l1la~ be
due to their lo\\CraClivalion threshold. A nt:gati\'e voltagenct i\:llion and s!o\\Crinncli,ation
allows Ca,1.3. during wl.'ak depolarizolliollS. to lIlcdialCa longl.'rc:11ciuminllu:Il:(Koschak
SinccC:1,1.3sublypcactivaleSalalo\\crmt:mbrnnc:voltngcth:1nCa,1.2. and bccausc
tht:yarcknoWlllobcpaccmakcrsandlhcmodululorsofnellronalliring(Slricssnig.l3oll.ctal.:
Platzer. Engc!clul. 2000: Sinncggcr.Omuns. Illlbcrctal. 2009). Ca, I.) may prO\c 10 bc more
crucial in lreating mcsolimbicdysful1clions such as addiclion. dtiC 10 bcingacli\ntcd bcfon:
LTCCsublypCC;:I,.IA(aIF)isconlinedtolhcrclinaundunderslandingwhalroleCa,IA
has in the rClina isbeSI seen upon ilscomplcledelclion. CnvlAdeficicnt mice sufTcr from
congcnilal slalionary night blindncss. which cuuses life-Iongnighlvisionimpairmcntand
rcdllccd day vision. ullhough no strllchlral abnormalitiesoflhc n.:tinliurcsccn(Slricssnig.Bolzct
al.;Doycotl. Pearce ct al. 2000). LTCCsublypeCuvlA is the 1llnill chunndcontrolling
nCllrolr:lnsmission cmission at the ribbon synapses inrctinal pholoreccptor terminuls (Slricssnig.







complcldydddingil frollllhegcnomcwasnol feasible. LTCCCa,I.2D~W-/.COlllplefC
knockolilsdienlcmbryonicdayI2.5aslhehcartn."'quircsCa,I.210fllnClion{Seiscnbcrger.
Spcchtclnl. 2000). Therefore in order 10 investigalcCa,I.2. a point mul31ionfromthrconinclo
tyrosincwasm3dcinlhealsubunilintheDHPbindingsilc.Cavl.2channdsfunclionnonnall).
but do nOl respond 10 DHP agonislsorantagonisls.sllCh as BayKornifedipinercspeclively.duc
loa loss of high aninilY binding 10 the DHPsile(Slriessnig. Kosc hakclaI.2006).Thisallows
for the dirTcrC111iaiion ofLTCC subtypes in fUllctional silidies: lhcrolcofCavl.3 will bcrc"cnled
whcnaDI-IPblockcrisapplicd.wilhthcrolcofCavI.2bcingcquivalcnllothcdilTcrcnccinthc
DIIP-scnsilivcporlionofaresponsebclwccnwildtypcnndthcCnv l .21l1 uWIlIS
Tbt:secondmoLlsclllodcl used in Ihcseexpcrimcl1ts isncomplclc LTCCSllbtypcCavl.3
knockollLlnCnvl.JhomozygollsrccessivcmicctheC<lvl.3a.lsubunit gene CACNAID was
illlcrruptcdbylhcplaccmcnlofaneomycincasscucil1cxon2(Stricssnig.KoschakctaI.2006)
ThisdcletionlcavesCa,I.J·/-lllicewithnoLTCCsublypcCa,I.JandthcrcforcnllcfTcctsseen
upon <lpplicalion ofLTCC modulators are becnuscofmodulatiol1 fO LTCC sllbtypcCa,I.2. As






rclevantandthccloSt:stchoicctohlimans.Spccifically.miccandralstend to bc lhechoice lab
~lIlil1lal. as they arc easy 10 house and reproduce quickly. Developing behavioral tests lhat
accliralclyrclk"C1 \\hm is seen in humans has bcen a conslant challcnge
ThcsymplolllsOrmClllalillnessesandaddiclionshaveplagllcdsufTercrs.andbel·allscofthis
havc been a primary focusofneuroscientisl's rescarchsincc the 195Os. The EPM. lhe lighl/dark
boX.lhcopcn licld. and social compclilion teslsnrcjusl a fcwcomlllon mcthOdSllscdtolCSI
uncondilionedanxielyorslrcssresponses(RodgcrsandDalvil997).l3othlcgalandillcgal
drllgshuvebcclltcstcdrrequclltJyintheconditioncdplaceprcfcrcncc(CPP)parndigm,llsingi.v..
s.c. (Grabus, Martin l:l al. 2006)ori.p. injeclablecompollnds(RisingerllndOakcs1995).which
allows testing the addictive abiJily ofa drug. Tcsling animals bchaviorally.usingdifTcrcnt
anirnllirnodcls.hasprovidcdrurthcrinsighlintollnderst<lndingilIncsScslhatnrcc!l:trilllcntnlto
Chronic nicotinc llSC in humallsmanifCSIS as mllltiple bchaviors. sllchasdccreascd
nnxicly.nppctite.moodelevntionandimprovcdconccnlration.T\\o lmtior aspects of why
anxicty.l-lowlomodcllhisbehnviorallyhasbecnachallcngcoc'Causc\\hl.:nanimalsarcllsedil
may limit the scopc orthe study as intervicwinglhcm isnol possible. rhcrdbrc. inordcr to
1ll0llt:lalldinvl:stigatcwh:ltroh.:LTCCspJayinallxil:tY:tllllmldictiVI: propl:r1il:sufnicotilll:thl:
EPM:llldCPPbdmviorallcstS\vcrcchosl:n.ThcEPMiS<l\\iddyknownandllCcl:ptcotcstthm
lTlcasurcsbothanxictyll.:vclandlocomotorchangcs.Thcaddictivcability or certain dnlgs \\as
lirstsho\\nintheCPPintheI980s:lI1disatnlstedtcstfordctcrmining thc addicli\c strcngth of
Using animals to model behaviors sccn in humans wilhollt lIsing noxiolls slimuli-suchas
dcctricshock. loindllce fear has Icd to using tests such as thc EPM. TheEI)Mitseifisbasedon
stlidicsthalinvcstigmedsponw.nCOlisandunconditioncdbclmvior(Rodgers and Dalvi 1997)
l3ascdona proccdure by Montgomery. the EPM takes <ldvantage of an ani IlUlI's naturnl desire to
avoid 0l>cnareas. llsthcy will inherently try and seck olltcloscd arcas.sllchaslhedosedannsin
lhe EI)M. Montgomery proposed that by being exposed tOll novcl cllvi ronmcnl.animals·




Iland ley and Mithani (1984) repol1cd thc use of an X-maze. raiscd 70 em above Ihe lloor.
consislingof4 unllS. I\VO opcn and t\Voenclosed (I land Icy and Milhnni 1984; Rodgers and Dalvi
1997). AltholighthiswasalllodificdmazccomparcdloMontgom~ry'soriginaI design. the







tcsl using Nalion:ll lnslitule ofHeahh (I II-I) Swiss mice (Lislt:r 1987). showing bolh ralsand
miccha\'clhcsamcbasicfcarandexploraliollinstincts
"nle EI)~l is a divcrse test as it has Ihc ability 10 Icsllllultipic calcgorit:sofdrugs. NiCOline.
cocaineand:unphclamineha\'call bccnshown to cause anxiolylic cni.:ctschronically.producing
incre<lscs in opcn arm time (I3rioni el al. 1993: BialaCI al. 2009: 13alcrioclaI.2005).ThcEPM
nOl only tests anxiety in nicotine or amphetamine addiclion. bu tcantcstantagonists.to
in\'cstigalc whclhcr lhey can dccrease orcomplclely abolish anxiolylicoram(iogeniccllccis
(Bialaand Budzynska2006: Bialaand Kruk2009). Bialacla1.(2009) showed that prctreatmcnt
Wilh bllpropion (an inhibitorofDA and a non-compctitiwunlagonistfornAChRs)dccrcast:dlhc
aClitcanxiogcnic(mol'cclosedarmtime)cnectsofbothnicOlincand amphclalllinc (BiaJa and
Krllk2009). The EPM can also be used to invcstigatcarcnsol'thcbrnininvolwdwilhfear.sllch
as the lill1bic regions. amygdala. and hippocampus (Walfand Frye 2007). which haw
involvclllcnt not only in tear and anxiety. butnddictionreinlorccmcnland mClIlOI'Y formation
invcsligate ways ofdiminishing both the acute and chronic ctTcctsonnllxicty
1.3.2. Conditioned placcprefl'rel1cc
rhe C1)P came into popular use in the I980s. lIo\\>c\'1,.'r il has been in usc for over 35 ~ cars
cOlll.lilioning in whidl on unconditioned stimulus. inlhiscasclht:t1nlgornon-dnlglrc:ltmcnt.is
p<lilX.-d with an olhemisc neulral slimulusrepeatedly. the chamber. OneClhcanimalaequireslht:
condilionillgtheyassocialclheonceneUlralslimulus\\ilhlhclinconditioned stimulus. lhctlnlg
orllon-t1rugtrcillmenLallowinglheinlcrpreterloseeiflhcanimalhasaprctercnceforlhednlg
given {Tzschenlkc 1998) as indcxed by the animal spending morc limC ill Ihcdrug-paircd
chnmbcr.Thcmainbrainareasinvolvedwithmedialingdrug-induct..-d place condilioning ure Ihe
VTAandNAc.howcverlhemcdialprcfronlalcorlex.pcduncliloponlinclcgmcnlnlnllclclls
ventrnlpallidulllandamygdalaarcalsovitalinlhercwardproecsscsordmgs(TzschcnlkcI998)
As in thc EPM. thcCPPdocsnol use aversive slimuli to induccplacc prererenec.insleadil
uses rcPClllCd doses ofeilher a eOlltrol or drug compound. followcd bybcingplllccdin IheCPP
011 1ll11ltipleoccasions.TbeCPPparadigmhasbccll llscd 10 lest a mult iludcofdrllgs.including
130lh l3ialacl al. (2003) and Risinger (1995) lcslcd miccinlhcCPPandfollndlhcy
displayed n slrong place prcfercncc for nicotine (Risinger and 0 akcsI995;l3iab2003).Placc
prefcrenccincachsllidyisdclcrminedbycomparingbasclinClimcspcntilll.:Hchchambcrbdorc
anydrugassocialion iseslablishcd 10lhe time spent in thechambcraflerdrugassocialion
(Tzschcl1tkcI998;Grabus,MarlinctaI.2006).TheCPPdisplaysdrug place prcfcrl.:nceas more
tirncspenlinlhednlg-paircdchamberovcrthcnon-dnlgpaircdcharnber.<lllowingin\'csligalors
10 lest Ircatmcnls for ~lddicliol1s within lhis paradigm
1.3.J.llowVTA IlAbursttiringrclalcslolhchchavioral:lspccfsof
As discussed carlicr. eh:ctrophysiological rcsulls Im\'c shown IIl<llcholim:rgicagonisls
(sllch as nicoline) induce burst-firing in VTA DA ncurons. increasing dop~lminc relcase. \\ hich
Ims lx"CnshO\\n 10 inilialc or pcrpctuale an addictioll (Zhang. Liuela1.2005). Research has
IOcllscdon linding the channel Ihat induces DA bllrst-firingfollo\\ingagonistbindingonDA
neurons. Debalcon whalindllccsbursl-firinghasmainlyfocust.'donchannclsprescnlonDA
widespreaddisiriblilion lhrollgholll the brain and entire body (Bialn2003:Erllon.Maciasclal
InorderlocollncctwhatisseenelectrophysiologicallyrcgardingLTCCsrolcinVTADA
l1curons. 10 what goes on in humanaddiclions. bchavioral teststhatmodcldrugelTeclsncedlobc
studi<..'d. It is hypothesized that nicotine's melhod of action foilowing binding to nAChRs on
dop<lllline llcurons leads to burst firing. an efficicllt wayufrcinforcinglhedrllg.throllghLTP.
ll1Clllory lorm<ltionand incrcascd dopamine rclcasc to thc NAc. 110wcver.rollowingnicotinc
billding.whichchannclslcdtocascndcinitiationandDAbllrstfiringslillremainsclllsi\'c.SOlbc





in \\hich mcsolil1lbic DA plays an csscntial role in both initialing andl1lainlainingaddiclion
LTCC blockade prcvcnls carbachol-induced burst-liring ofDA cells.suggcslinganinlcrCsling




bchavior..llolilcorncs frolll IhcCPPpamdigm ina Grnbllscl al. (2006) study.whichshowcd
nicolincinduccdaslrongplaceprcfcrcnceinC57I3U6Jmicc.whichwaslhcbackgroundslmin
lIscdtodcvdoplhclmnsgcnicLTCCmouscmodclbySlricssnig(Grablis. Martinclal. 2006:
Stricssnig.KoschakctnI.2006).Cavl.Jappcarslobcpositioned10 play a morcpromincnt rolc
inaddiclionlhanCav l.2.ducloaJowcrnClivatiolllhrcshold.1c<ldingloahighcrprobabililyofil
participalillginLTCC.induccdbllfst-firing,ci+inllux.n:sultinginLTPfofll1ation(Koschak.
Rcimcfctal. 2001; Ilclton. Xli ct aJ. 2005)
rbec:.. pcrirncnlsinlhislhcsiswcrebascdon in vitrorcsllltsofbll rstliringwilhinthc
rncsolirnbicsystcrn.whichwhcniniliatcdbycholincrgicagonisIs. sllchas nicotinc.activatcs
LTCCsprovidingthcccltularmcchanismforaddiclivebehaviors.\VcSCi Ollt 10 illvcstigntc
\\hcthcrCa.I.20rCav l.Jhadastrongerrolcinnicolincaddiclion.llsingl",'otransgcnicmouse
1.~.2.lIy"othesis to be lesled
I) Whctht:fnicolinc's:mxiogenicandanxiol)ticcITcClswllldbcmodulatcLlbyLITC
2)\VhichLTCCsubl)pe.Ca,I.2andCa,I.Jmcdi<llCchronicllicotilll.:'sanxiol)lic




Expcrimcnts in this Ihesis were conduclcd onC5713U6J mice and Iransgcnic strains \\ilh
aC57I3U6Jb.'lckground.Wildtypc(WT)micewcrcpurchascdfromCharlcsRi\crCanada
Iransgcnicstrains\VcrekindlyprovidedbyDrs.Slricssnig(Univcrsityoflnnsbruck. Austria) and
Rajadhyaksha(ComclJUnivcrsilYol Y. USA). All procedures involving animal handling were in
accordanccwithguidclincsputinplacebythclnstillllionalAnimnlCarcComl11ittccallhc
MClllorialUnivcrsilyofNcwfoundlulld.Miccwcrcgivcnloodandwalcrad libitum and houst."d
in a room on a 12~hour lighlldark cycle with temperature maintained al 24°C
2.1.1. Tr:.lnsgcnic mice strains
Transgenic mOliSC breeders wcrcrccciwd frorn Dr.Rajudhyakshaand brcdollsite.£3olh
transgl:niClllouscstrainswcrcbackbredinlotbcC5713U6Jgcncticbackground.\VTllliccwcrc
brollght in frolllCharies Rivcrcvcry6-8 l1lonthsandinlroduccd into Ihcslrainloprovidca
varicdgcnclicpooI.ThcCa,1.2DHP·/-micecarryaninscnsili"cDIIPsilcintheCa,1.2subt)pc
byapoinlmlitationrrOl1llhrconinclolyrosineinlhca..sublinitinthcDIW·bindingpockcl.
kaving 1!lI:Ca,,1.1 Challlld nul rl:spollsive 10 DIIP agonists{Ba)K) tJr alllagonisis (i.l:
llili:dipinc.nimodipilll:).\\hilcthcCa,I.JdmnndisstiJlresponsivc10 DllPagollislur
:uHagonisls. The Ca~I.3 sirain is a C;1~1.3 kl1O\:k-Olil lhal docs nOI haw Ihl: Ca, 1.3 sublype in
theirgcnomc.\Vhilclhcrearenokno\\ndcficilsinthcC:l,I.'1D1II)·/·slrainlheCa,I.3./.mice
havcabnormalilicsSllCh;:IS bmd)'cardia. deafness and an antidcprl:s5.1ntlikcbcha\ior(Clark.
aganoetal. 2003: Slricssnig. KoschakctaI.2006: BllsqllCL Khoi gu)clletal.'1009)
2.1.2. Brccdingp:lirs
I3rcedingpairswcrckepllogclherforlifeandlhcirpllpsweren:movcdal2ldaysold
r)llpS were ear lagged and gcnOlyped (Section 2.2.). Mice wcre houscd\\ilhsamc-scxsiblings
andkcptlogclhcringroupsof2.4ullliltheywerellSt.-dinll:sling.alwhichpoinlthcywl:rc
housed scpamtcly one day before handling. Ca~I.J·/· li:malcs were poor breeders because lhey
often llliled toattclld to lhe plipS. To increase the yield orCa, 1.3·/• pllpS, a bn.:eding group
InollrCXpcril:ncc. inclllsionofahclerozygolls lcmale helped pup sllrvivulbythalfclllale





t\.licc\\crcgcntly reslrnincd and lhcn approxim3lcly a centimc:lcroftuil\\asrcmmcd.Thetail
was pl3ccd into a IUbc with 600 pi frcshly made lysis bulTcr(Fishc:r Scienlific.PA.USA)wilh
4%prolcinl:scK.TubcswcreputonarotatoraI50"CandI20rpmovemiglu.foJlowcdby
centrifugation for 30 min m 15.000 rpm. The supernatant was collected ~llld 950 ~d of 100%
cthanol was added followcd by prccipitationofONAat-20"C for 1_2 Ius. h was lhcn
ccntrifugcd at 4"Cat 15,000 rpm for30minand the pcllct wassavcd amldriedinaspecd
VaCllUIl1COllccntflltor(Savant)for5-20min.50-150pITE.pI18.0.was added lo dissolve the
DNA in a 70"C w:lterbalh for 3-4 hrs, or Ulllil completclydisso]ved.DNAwllsslorcdina-200 C
[n order to do DNA extraction. 60-80 ~d of the dissolved DNA was used while 20 ~tl W:lS
reserved. For extraction npproxill1ately 60-80 ~tl of chloroform/isoamyl was added. vortexed and
spullatlJ.OOOxgforlminandthcnthcsupernatant\\asrclllovedandsct aside. This was done
Iwicl:l11orc.oruntilsunicicntcontaminatcswcrcrcmoved.Thcnphcnolchloroform:iso<uuyl
alcohotw:lsndded.vortcxcd.spunat 13,OOOxgforl min and again thcsupernm:lnt\\as
All solutions\\cre prcparcdoll icc. TooptimiLC thcwllounl oftemplate. ONA was
Eilhcr 3 or 5 pi of 01 A. respectively. was added 10 cnch corn:sponding vi~ll. The PC R reaction
\\as gClllly mixed and cnpped by a drop of mineral oit (Sigma. SI.Loliis. USA).Ca\I.3.I-PCR
reactions had a hoi Slart thai n."'qllired the PCR machinc 10 heat upto 95°C bclbrc placinglhe
vialsinlo Ihe machine. The vials were left 10 process in Ihc PCR machincaspersctcycles
Ca\I.201-1I)-I-PCRswcrerunasfollo\Vs:9.J°C for 5 min. followcd by 30 sec al 9.J°C. 30 st."C at
64°Cand30sccat 72°C lbr 30 cycles and then held aI4°C. C'I,I.J-I-micc \\cre run as follows
94°Clbr5min.follo\VedbylmillaI94°C,tminaI55°Cnndthen40scCal 72°Cfor32cyclcs
2.2.3. Gcl clcctrophorcsis
A 2.5% agurosc (Fisher Scicntifie. PA. USA) get was prcpnrcd (1.75 gwitb75mlTAE
buller) by healing thcagarosesolulioll Ulllit ilwas fully dissolved.buldidnolbubblc.\Vhcllthe
mixlurewassutlicicnllycoolcd.O.5pg.!mlclhidiumbromidc(FishcrScicnlilic.PA.USA)w<IS
added and thL'1l thcmixture was poured illioacnsl with a comb and aJlo\\cdtoscl.makingsure
noairbllbblcswerepresent.rorI5-20min.Onccpolymerizcd.anmllingbuOcrorl.TAEwas
addcd.comptclclysubmcrginglhcgcl.andthecomb\\asrcmovcd
DNA s:ll11pll:s\\cn:pl'cparcd byaddingJ pi (inloJO,t1)orS ,d(inlo50pl)oflOxDNA
loadingdyclocnchtubc.lorCa,1.2andCil,l.JPCRsrcspecli\cly.20pi OfC:1Ch rcaction was
,II of DNA laddaslock(Oiolabs. New England). 70 III of rE pliS and 10 ,II Orlo~ldillgd)e. The
rcaclioll\\;:lsrunaI160mVuntillheDNAranlhroughlhcgcl
2.2A.GcnolypingChcmical





pI18.0. I mlol'20%SDS.4 mlofSM NaCi and 84 ml of1120. which had bcen lhroughrcverse
Ca v I.201'-IP-I-gcnotyping r~:Ictioll mixture
22,11 01'1120 was add...-d 10 a smalltubc. tollO\\\:d by J ,II of 10·bllIT~r (\\ilh J\lg)
(Invitrogen. USA), 0.6 ,II ofdNTP.0.9 ~d orKI priruers«0.2 ,1M Loxup2 primer (S'·
rCCTGCACrrAGGTAAGATGCAAAGGC·j') (Fish~rScic:ntiJic, PI\. USA). 0.2 ~I~I Screen I
primer (S'-GAACATGAACTGCAGCAGAG rGGT-J') (Fisher Scicntilic. PA. USA). 0.2 ~IM
alc\,rtprimcr(S'·GAACATGAACTGCAGCAGAGTGTA·3')(FisherScicl1lific,PA,USA».
andfinall) O.S pi ofTaq (1Il\itrogen. USA), \\hich was kept ina·200c frcezcrul1liluscand
whi Ie in usc was kept on icc. The lotal reaclion mixlure for each DNA sample was 27 ~II, \\ ilh j
~il of DNA added aller Ihe KI mouse reaction mixlure was aliquolcd into scpamte peR lubes
Ca v l.3 knockout genotype reaction mixture
36.7111 ofl-120 is added 10 a small tube, followed by 5 ~i1 of 10·buffer (with Mg). I ~d of
dNTP,1.8plofKOprimers«0.5pJExonup5primcr(S'·GCAAACTATGCAAGAGGCACC-
)').0.8pJ Ncollpprimcr(5'TTCCATn'GTCACGTCCTGCACCA-3').0.5~dExon2 Lower
pri1llcr(S·-GGGAGAGAGATCCTACAGGTGG.3·(FisherScicntitic),PA, USA» and linaJly
0.5 ~tl ofTaq (Oiolabs, New England, USA). which was kept in a ·20°C freezer lllltilllse and
whi Ie in usc was kept on icc. The mixture for each sample tOlaled 45 ~i1 nnd following al iquoting
2.3.1. Elcvalcd Plus Maze design
rhcEPMwasbasl'donadesignolillincdbyl3ialactal.(2006)(lJialaundlJlldz)nsku
2006). The m~lL.e \\a5 designl;.'{\ Iike a "plus" sign \\ ilh two open arms (30 :'( 5 cm). 1\\ 0 c1osl.:d
an11s(30x 5x 15 cm)and acelliral platfonn(5x 5cm)(Biula~llIdlJud,tynsb1006). The floor
oflheplatfonn wasmude from whitc Plexiglas. which wasbutfcd smoolh.whilclhcsidcsofthc
muzc \\'l.:rC made from dark Plexiglas with only Ihcoliiside butTcdsmoolhlorcmo\'elheshinc
and crcalc a darker inside tor Ihc c10scd arms.Thc \vhitc Plexiglas iSllscdforlhcfloorinorder
lodisiinguishihebinckmiceonlhcrccording
2.3.2. Elevated Plus Maze procedure
Male Ca~ 1.2DHP·/- and WT mice (age 8·12 weeks old) wcre used in the EPM. Micc
wercindividuulJyhollscdoncdaybeforelmndlingbcgan.Theywerc handled for 3 min each day
lorJconsecutivednys,priortothestarroflcsting.llandlingconsistcdofmice being gently
slrokcdund grippcd and placed inan injeclionposition. On tcstingdaysl.7and8miccwcrc
injcctcd intmperitoncally(i.p.) withcithcrconlroJ solution (10 mllkgoflhc nitcdipinc "chicle) or
nilcdipine(Sigm:J.SI.Louis.USA)IOmglkglIOml.toJlowcdI5minlatcr by subclltancolls (s.c.)
injcclion ofs..1linc (10 mVkg) or nicoline (Sigma. SI.Loliis. USA) O.lmglkglIOml.Ontcstdays.
5minfollowinglhcs.c.injl.:ction.lhcmollscwaspln.ccdinlolhcmazc facing a closed ann and
thl.:ir l.:xplor:uion \\:15 rl.:\:ordcd by \'id~o CUllCf:l tor 10 min. On days 2·6 mil.:\: \\crc injl.:\:tcd as
pn.:viouslydcscribcdandwe:rl.:rl.:turne:dtothe:irhome:\:agl.:lollowinglbe:injcction.Amousc\\as
\:onsidercd to have entcre:d Cilhl.:r an open or closed ~Irln \\ hen all lour paws wcre inside Ihe: ann.
cxcl ud i11g the.: tai I. The m~IZC was wi perl c1can wi Ih a damp cloth OCI wccn tri 11 Is \\ it h dilTcre:n I
mice:. ~Iousc groups \\cre as loltow: Control/Control or C/C (\:ollirol group ofS::llinc for i.p. and
s.c.).ComrollNicotincorC (S::lline.:i.p.\\ithnicotincs.c.).LTCClNicotincorLTCC/N
A prcmadc S<1linc (Abbotl Laboratories Lid.. Que:bec) W::IS llscd asa nicotinecol1troland
in preparing the nicotine solution. icotille(O.lmglkg/IOml)(Sigma.SI.Louis.USA)was
administered s.c. (l3iala and Budzynska 2006). Nicoline was frozen in 120 ~d llliquots and
lhawcd whellnccdcd. then 1.08 ml ofS<1line was added to bring it 10 the correct dosage
Nifedipinc(JOmg/kg/IOml)(Sigma.St.Louis.USA)wnsadministcrcd i.p. (Bialaand
l311dzynska2006)ina30%PEG/2%DMSOsollltion.AliqllolSofJ20~tlofnifcdipincwerl.:
tlllldc. l"rozl.:nand tha\wd when nccded. when 1.08 ml oJ'vchicle was addcd to bring it to thc
proper dose. Thccontrol lor nifcdipine (10 mllkg) was the 30% PEG12%DMSOsolution.PEG







rt:lllo\,('dopcned up bolh chamber 10 foml one allowing the mice to t:xplorc.ThclcHchambcr
had4mmmt:tal rods spaced 3.35 mmapart and Ihc wulls had a vcrtiC'11 black and \\hiteslripc
dcsign.lllcrightchambcrhadstainlessslcelnooringwith6AmmhoIcswilhslaggt:rcdcenlcrs
andlhcwallshadahorizOIllalblackalldwhilcslripedcsign.Thcdcsignstorbolhchambcrswt:re
made and IhcntapcdolltOIhcolltsidcof the box in order to kct:pIhcmfro mbccominga
distmclionforlhcmicClobilCOll.Thcnooringofbothsidcscontintlcdintothecclllmichambcr
so Ihat when the doors wcrc removcd. it appcarcd as ifitcontaincd onlytwonoors.Thisnllowcd
thcll1icctobcnon-biascdwhcnplnccdinlhccclltrlllchambcrlor5min.Thcsidcsofthcccntral
Z....2. Condiliollcd Pl:lcc Prefcrcllcc procedure




was tollowcd as pcr Grabus ct al. (2006) with slighl modificalions(Grnbus.I\lartinctnI.2006)
Oncdaypriortohnndling.themicewcrcindividllallyhollscd.llandlingandhabilualionwerc
condllcll,.'dlhrecdayspriortothestartoftcstingin\\hichmiccwcreplaced illloadimly lit room
(lightcovcrcdwilhrcdlisSllcpaper)aIIOAMandallowcdlohabiluate lorlhreehours. Mice
wcrclhcn handlcd for I min. which consisted ofbcingscnlfTcd and slrokcd gcnlly. Miccwcre
point thcywcrcmovcdbuck inlothcirholdingrooms
OnduylmiccwcreplacedintotheproccdllrcroomatlOAMandthenpJaccd individually
into thccclliral chamber ror5 min. Followinglhe5-minhabitllation timcthcdoorswcrc
removed and thcy rrcclyexplorcd the chambcr for 15 min whilcbcingrccorded.AnYlllollsClhat
had a bias ratio rorcithcrsidcovcr60:40wercdiscontinllcd.Ondays2·4 rnicc were placed into
the proccdllrc room at 10 AM and salinc(lO ml/kg) s.c. wasgivcn toa lI111iccdllringthclllorning
condilioning.Allinjcclionswercgivcndircctlyoverthccorrespondingchambcr. followcd by
imlllcJiatdyplaeingthcmiccintothedrug/conlrolchambcrlor30min.Morningandartcrnoon
injcctiollswercscparntcdby5 hrsand mice remaincd in thcproccdurc roomlintillhclasl1l101lSC
wastcslcd lorthcd<lY. Afternoon injections followed thes.1lllc proccdurcas morning ones but
\\crccithcrsalinc.lorconlrolmicc.ornicotinc(O.5mg/10mllkg). rormiec in the dmg groups
Nifcdipim:orI'EGcontrol solUliotl(IOmglIOml/kg)\\;lsgiH:nI 5 min prior to salinr.: or
nir.:utinc.andmicr.:wr.:reinjr.:ctcdandlhcnplaccdinthcirhornccagclorthcl5min.Thc
chambcrs were dr.::lncd belwccncachuscwithadampdoth.Onduy5 Ihcproccdurclollo\\cd
dayl.cxccptvidcorccordingcaplllrcdduringthiscxploralion\\asllscdlodetermincifplact:
preference occurred. Th~ mouse groups were as follows: Conlrol/Control orC/C (saline lor s.c
and nicolincs.c.). COl1lrol icotine or CIN (saline and nicotine s.c.). Conlrol/Comrol \\ilh PEG
orC/C with PEG (salinc lor s.c. and PEG i.p.).ConlrollNieolincwith PEGorC/N "ilh PEG
andnicotincs.c.wilhnifcdipinc(LTCC)i.p.)
Saline wns made wilh double deionized watcrand NaCi to give a tinal conccnlrationof
(0.5 mglkg/10ml)(Sigma.SI.Louis. USA) W<IS mi.xed in saline and adminislcrcd s.c. Nifedipine
(10 rng/kg/IO ml) (Sigmu. SLLollis, USA) wasadministcrcd i.p. (13ia la2003)ina30%PEG
(New Jcrscy. USA)/2% OM SO (Sigma, SLLouis. USA) Solulion. Tbccollirolfornilcdipincwas
theJO%PEG/2%OMSO(scesection2.5.2)solulionadministcrcdntl0rnglkgllOmi
2.5.0ataaudstatisticalanalysis
All d~lta \\crc cxprcss~das rn~ans and standard ~rrors orlhc lll~an. One and h ..o and
Ihrt.'C-\\ayANOVAs\\creused,asapproprialelorlhccxpcrimcIlIOIdcsign,locomparcgroups
A OVAs\\Cfcperforl11edonrawdata\\ilhlhcsignilkancclc\,clscl:llp<O.05. Forcomp<lring
di I1crenccs bcmecn two time points. t-h.·sIS \\ ere ~llso used
2.5.1. Gcnotyping
Followinggelclcclrophroesis,thegelwusrclllovcdrromlhcchambcrandplaccdonu
lluorcsccnl lighlbox in order ror Ihc bandsloappcar. Thcn. accordinglolhcDNAladdcr,\\hich
hadknownbpmcaslIrcmenls.lhebandslorcachmOllscwcrcdctcrmincdasperTablesland2
Iranybands wcrc 100 liglu thcywcrelhcn placed back 10 soak inahighcrconccntrationor
cthidium bromidcsolulion lor 20-30 min. Any bands Ihat wcrc notscparatcdsliflicicnltyorwerc
lootightwcrcdiscardcdandthcgclswerererun.SccTabtcsland2forCa,,1.2DIlPandCu,,1.3
2.5.2.1. Open/closct!armtimc4Int!clllrics
Opcn ann time is (he stnndard 10 qllanlifYanxil:ly \\ithin Ihe EP~I, Opcn ann t:ntrit:s in
comparison 10 close ann entries are used as a measure or gcncml aCli vily. Original d~lta shm\ t:d
opcnaml timc in seconds. displayed asaratioo\,crtolal lime. l1lultiplicdbylOOlogi\ca
pcrcclliage. ThCS.l111C was done lor open ann entries. i.e. Ihcopcn ann elltriesnrcgi\cnaSamlio
was nommlizcd 10 controls as 100010. so lh31 anychallge due to drugs orotherwisecollldbc
plainlydislinguished. onnalizationconsisledorusinglhcconlrol a\'erage as thc bascl inelo
comparc the drug group. expressed as pcrcclltnge
ANOVAs were performed on relevant groups and t-lcslswerc llsed todctermine




ProtcctcdslrctchattendsrcrerloamOlIscstretchinglorwardinacloscd arm. or within the closed
amlbutslretchingtowardsanopenann.andlhcnrClmclingthcirfrontpawslotht:iroriginal
posilion,Unproh..-ClellstrclchaltC'ndsrc!crtoumouscstrclchingforward",ilhinanopcnarm:lnd
then retracting to their original position. Protected head dips arc when :l mouse ~Irdchcs fwm
within thcc!osed ann. leallS over the open aml and thcnretractslOthcirorigillalpositioninsidc
the cloS4.."'d llrm. An unprolcctcd head dip is\\hen a mouse stretched overthcopcnann.\\hilcin
theopcn ann. All lour types of stretch allcndsand hl,.·.lddips were COlintedduringthclirst5min
inthcEP~landc;l(prcsscdasana\'erageforcach£roup(\Vall.l3bnchardClal.:WO..J).Strctch
<:lllcndsandhcaddipswcrccomp..'1rcdusingt-h:stsandone.W3yA 10VAs to dcterminc
significance. which wassct at p<O.OS.
In the litcrnturc{Grabus. Martin et al. 2006). place prcfercnce isachicvcdwhcnthcmicc
showaprcfcrcnccovcrlOOsecondsforlhedrugsiderciatiVl:tothccontrolsidcduringal5min
tcSI. My test groups includcd tmnsgenic animals that mightnotdcvclopaprclcrcncelornicotillc
solmodificdthCC;I(c1usionandinclusioncritcria.l3othprcfcrcllccsandavoidanccsofthcdrllg
prcfcrrcdchamberfornicotinc wcrcllscd in the statisticul analyscstoc;l(umincwhcthcrtherewas
<lIlactllalplaceprcfcrcllcc.Prclcrcnccswcregivcnaposilivcnumbcr.whilcilvoidanccswcrc
inc!lI{lcdasncgativc valllcs, and llpon totalingthc valucs fromH II miccifthcrcwas a positivc
V.tlllCovcrlOOsccondslhatwasconsidcrcdaplnceprcfcrCilcc
Following a rcvicw of day I videos. ifany mOliSC had u ratio of more than 60:40 tor
cithcrsidcduringtltcscrecninglcsl(beloreanydrugswcrcinjccted). they wcre c;l(c!lldcd from
thcc;l(pcrimcnl.Anycrrorinprocedurcwasnolcd in the animal log during thi: c;l(pcrimcnt and
thcscmiccwcrcalsoc;l(c!udcd.Placeprefcrcncewasdclcrmincdby taking thcday5 time
(rcpcated injcclions) from Iheday I lime (basel inc. no injcctions) and a prcfcrcncc was
dclcrlllillcd tohayt,:occurrcd iflllicc prclcm:d the drug sitk lor appro.... illlaldylOOsccolldsor
ChapterJ
3.I.Gcnotyping
Following the steps outlined in the Section 2.2 of the mClhods. DNA was extrnctcdandPCRs
were run (Sl.'Clion 2.2.3) in order to dClcnninc the genol)'pc Of;:lll miccuscdincxpcrimentation
J\ssccn in Figure I the bandsarcdislinguishablcagainst;:lknowll 0 NA ladder on the left
sidcorlhcgcJ.Thclopband.thebandcloscsltothcwclls.ut475bpislhcCu.1.2DIIP-I-
hOlllOZygOlis rcccssivc mice bnnd (-1-). whilcthcbollom banda139obpcoincidcs with the
hOlllozygousdomin:1ll1orWT(+I+)gcnotypc.Whcl1botharcprcscntilrepresents a
I\ssccnin Figure 2 thetop band ul390 bpsignificsthchornozygollsrcccssivcCa.I.J-I-
gcnotypc. while the botlom band at 180bprcprcscntslhcWTgl:notypc( r/+).\Vhenbolharc
FigUl'cl:C:I •. 1.2miccgcnolypingrl'sulls
Th..:DNA ludderrllllsalonglhc Ielt side. A single lOp bmlll(475 bp)idCllliliesahOlllOl.)gOlIs
rcc..:ssivc (-1-) or KI (C:lv I.2DIIP-I-)mOllsc.\'vhilt:lhcpr,,:scI1CCOfl\\O bands (475 and 390 bp)
idcnlilicsnhctcrozygolismouSI:(+I-).andasingkbottomband(390bp)idelltilicsaWTmolise
Figurel:Ca.I.Jlllil.'cgl.'llotypin/-:rcsulls
The DNA ladderrllllsalongthc]disidl.',t\ singlctopbantl(J90bp)iul.'ntilicsahollloz)golis
rl.'cessin:(-I-)orKO(Cav I.3.1-)molisc.whilctheprcscnccoft\\obantls(J90andISObp)





2007: Bialaand Kmk2008). Unprotcclcdstrctchattc:ndsandhc:addipsarc: used as indicator.iof
dt.'crcasing anxiely. whi Ie an increase in protected stretch ~lIIcnds andlor a head dips indicates
Inourc:xpcriment.conlrolWTandCa,I.2DI-IP·/-lllicct)picatlyspcntJO...W%ofthe
timc in Ihcopenaml following s.c. injcclionofnomlals..1line. Aner7dJysofsaiineinjcciions
the control miceshowcdrcducedopenamllimc(FigureJ)(WTC/C frol1l 30.90J,±,2.21Io
IO.61243±3.27n=8andCJ,,1.2DHP-/-C/Cfrom30.526.±.3.0Ito25.1.±.4.iH n=IO). DliCtO
thisdiscrcpancywcchosClonomlalizClhedataagainstc..1chmOlISCconlrol group. in order to
Asscc:ninFigllre4.upOllnormalizaliollofallaclltc(sillglctrcaIlllcllto(salineor
nicotinl.:) mouse groups. nicotinc's clTecls are easier to illtcrprCLUponllormalizingthe
Ca~1.2DJ-IP·/- nicotine treated mice (n= t 1). anxiolytie clTccts from a single 0.1 mglkg nicotine
Ircatmcnt wcrCSCCll. as compared to the control grollp(t-test p<O.05;C/ClOO±9.88D7.CfN
IJD.146.±.9.296)(Figure4).WTnicotinctreatcdmicc(n=9)didnotrcHchsignificallcc(Figurc
4).showillgasingkdoscofllicotinchadlloanxiogcnicclTectonthcmHSSel:nin l3ialactal
(2006)(1-lcstp>O.05,C/C IOO± 7.16. CIN 114.902±4.711)
Fi~t1rc .,: Ca,.1.2DIII'·/- anti \VT mice :.:rtlups shu\\' l'xpl'cled 30%, tllll'lI arlll lillie fur a
single dtlsc tlfnieolinc. Non-llonna[izl;:ddatashowsthl;:actlte~xpccted30%orslightJyhighl;:r
open armtinw, se~ll in all groups, dl;:spite nicotine administration in 4 groups. Following 7 days
orrep~atl;:dsalillctreatl1lcnt(chronicphase)WTcontrolmiccshowl;:dasignilicHmdccreascin
opcnarmtimc(30%.IO%)(t-tcstp<O,05).whilcCuv l.2DJ-[P·/_colltrols (30%-25%) do not (till1c
Acute (IS1day of treatment) Chronic (7'h day oflreatmcnt)
Fi~urc-l: Nurm:IJiI.4,.'d open :lrlll timc rorC:I,.1.2U1II)-/-alltl WT lIIin·shom..·t1 :llIXiulylic
IrcalcdmiccshowaJO%incrcuscinopcnaml limc.comp:m:t1 10 coni rols(C/C100%.C
IJO%).whilcWTmiccshowllmurginalincrcascfromlOO-115%.indicating a single dose of
nicotillccauses:mxiol)ticcITcctsillCa,,1.2D1IP·/-rnil:c.bulinWTl1licenoanxiogcnitelTccls
arcsecll posisingicnicotinc injection (p>O.05)
Abn.:vialions: C/C (ControI/Comrol).CIN (Conlrol/Nicolinc)
adccrcnsc in c10scd arm limc (I·tcst p<O.05). indicating 1cssan~icty(Figllre5).Thcrdorc.thc
gl:llcraltrl:ndlorlhcopcnnrmtimcholdstnll:inthl:c1oscdarmtime.inthatnicotinc'sanxiolytic
dlcclscoll!>l:sceninCovI.20IlP·/·mice.blllnolinWTmice.AcUleopcnand closcd aml
I:lllrics did not show any di tlcrencl.'s bctwl..--cn control ~lI1d nicoline treated mice. regardless of
stmin(l·wny ANOVA and 1-lcslp>O.05. Figure 6). Although nicol inc tn..:alcd mice for both
gcnolypesshO\\l:dslightlyhigheropenormentries(WTIIOOloandCa,l.201IP·/-108%).and
c1oscdamlcnlriesmirrorcdlhiswilhaslightdecreascincloscdamlclltries.significance
(p>O.05) wnsnot sccn. Nicotine, thcrefore.docs notadvcrsclyatlcctmiccc:<plof3lioll
Asmentioncdprcviously,slretchaucndsandhcaddipsmaybeuscdincombinationwith
rcsllhsshowedthatthereWilsllodifTerenccsecnwhenSlrainswcrccomparcd Wilh head dips and
slrelchallcnds(ANOVAp>O.05).indicatingnoovcrallstrainditl'crencc.Unprotcctcdstrelch
altcndsprovcdcxtremclyinsightfulforevaillatinganxiclylevclaclilcly(Figure7).<:lsthcy
coincided with open mm limc.showingCavl.2DlIP./-micclmdadccn:asc in anxiety through a
significantincreascin lInprotcclcdslrctchallcnds(One-wnyANOVA and HCSlp<O.05). An
slrctchattcnd rate (Figurc 8)thnn Cuv l.2DHP-I· mice. protcclcd strctchatlcnds<lrcsimply
exploratioll within closed arms. and so llnprotcctcd strclch altcnds and hcad dips give aclemcr
Cavl.2DIIP./.miccloshowasignilicantdillcrencc\\ithadct.:n:ascorI5%.fromIOO-85%
(p<O.05) incloscd arm limc. No significant diflcrl.":l1cc isscl.":n fromasinglcdosl.":ofnicotilll.":in
WT micc (p>O.05). Rl.":pcatl.":d nicotinctrealcd WTmicc showed asignificantdccrcasc(rromIOO-
72%)\\hl:n comparcd 10 controls (p<O.05). ho\\c\'cr no dilTcrcncc issccninCa\I.2DIIP-/-micc
A decrease in closed ann time indicates Iessanxictyas it corrcspondstoan increase in opcn aml
Abbrcviations:CIC(Control/Colllrol).CfN(ConlrolfNicotine)
Fi~llrc 6: Ih'IIC:llc{llrc:ltmcnt. hut nol a sin~lc t1usc ul'nicutinc. incn':lSl'd upen :Irllll'nirics
in WThulnul C:l\,1.21>111'-/-lIliccoNcilhcrasinglcdoseorsalincornicmincincrcasedop\.on
ann entries in WT or C:l~1.2DI-IP·/· mice (I-tesl p>O.05). Rcpcal\.'d nicotine treated WT mic!:
sho\\\.'danincrcascinopcnannenlries(p<O.05).reflectinglhcirincrcaseinopcnamltimeand
Icsscn(.'dnnxiet)'.NicotinetremcdmiceincreascopcnannclltriesbyJO%.\\hileCa\1.2DIIP·/.
sho\\ed no dilference. ngain corresponding wilh no change seen inopcnarmtimc
Abbreviations: C/C (ConlroIlControl).CIN (ColltrollNicolinc)
3.3.H.cpcatcdnicOlinctrc:ltmcntsc:.IlIscdanxiolyticcffcctsin\VTbutnot
R~pcm~d nicotinc (chronic) was also ~\ahmtt:d through bchavior.lll~sling in Ih~ EPM
Nicotine's ~lIl.'I(iolyticcft'cels wcre St.'Cn \\ hen Ihe chronic (repented nicotine tremmcnt) treatmc:nt
foropcn arm limc wascompan:d between thecol1lrol and nicotine groups. Onccagain Ihedata
wasnonnalizcdtoconlrolinordcrloruleoulanydilTcrcnccsbct\\ccnthe control groups
Figure II showsnieotinc'schronicanxiolyticdTcctswithinWT(HCSlp<0.05)butnol
Ca~I.2DHP./.micc(Hestp>0.05).assccnfrom an incrcasc in opcn ann time (WTC/C (n==8)
100 ±30.83%. CIN (n~9) 152.46 ±11.16%: Ca, 1.2 DII1'·/- C/C (n~ 10) 100 ±18.467%. CIN
(n==ll) 107AO± 10.07%). Thisagn..-es Wilh Bialactal. (2006) rcsearch.inwhiehmicespcnl
morctime in lhe open arms rollowingrepcated nicotinc injections of 0.1 mglkg (lliala and
lludzynska 2006). Sillce WT and Ca~1.2DI-IP·/· rcaet differently 10 nicotine. it would appear Ihat
Jespitc the developers of the strain having seen no outright defects in Ca~ 1.2DlIP~/. mice. there
appearstobemolcclliarchangeslcadinglhcmtorcacitodrugsailldillcrenl rnleorlo process
thern in a slightly different way than WTmicc. Closed arm lirnc(FigUl"e5)onccagailllllirrors
opcnnrmtime.wilhWTnicotinclrcatcdmicedisplayingasignificalltlylowerpcrccntageof
As seen in Figllrc6.opcnarmcllIricsincrcascd lollowingrcpcatcdnicolincIrealmCnlin
WT mice (C/C 100±26.CIN 128.13±9.07)\\'ilhsignificanceofp-\'aluelcssthanO.05.\\hil~
Ca~1.2DIIP-I·llicotillctrl.'ah:dmiccwcrCIlOlanl:ctl.'d (1'>0.05. both fromHI".·sts). Wrchronic
open ann cnlrics incrcascsulmost 30%. loJlo\\ingrcpcatcd nicotincadlllinistration.coinciding
\\ iIh the inc rcase in open arm ti me showi ng 11 icotine lllay increase ex ploratory beh~l\'ior in \V-I
mice. We \\crc intcrestt.'-d in the fact that Ca~ 1.2DIIP-I- did nOI respond 10 chronic nicoline as
WT mice did. which ns mcntioncd in Ihc prcyiollsscclioll may beduc loothcrmolcclilarfaciors
whichh:lyellotbccllnoticedbcforeinthesemice.sllchasch:lngcsincndogel1ollsopioidsoran
llnex~clcdrolcorlheDI-IPsitc.whichwillbecxplorcdfunhcrinthcdiscussion
Although repeated nicotine treated Ca~1.201Ip·l- mice did show more unprotected stretch
allends(Figure7)lhilnWTmice(ANOVAilndt-tcstp<O.05).thissimply means that \\hen
Ca~1.2DI1P-I-l1liccwcre in the open amlS they cxplorcd morcthan WT mice. but since they did
llOt also show an increasc in opcn arm time. there isno realdecrc:lsc in anxiety. it just implies an
incrc:lse in exploration while in the open arms. \VT mice showcd nos ignificantincrcasein
lin protected slrclchattcnds following chronic nicotine (ANOVA andl·test1'>0.05) (Figurc7)
Protected stretch ntlcnds, in \\IT and nat Ca~I.2DIII)·I-mice. showed a significant decreasc (t·
Icstp<O.05)(Figurc8),shawingWTmicedisplayedlessanxicly.Unprotcctedandprotectcdhcad
dips(Figun.:s9andl0respeclivcly)didnalshawanysignilicantdilTcrcncelollowingrcpcalcd
Fi~urc 7: Unprolccll'd sfn:lch :I11cnds show a t1ccn'asl' ill aw\:il'ly fIlIlH\\in~ .. illl!ll' and
rcpl':lfcllnicOlincinjccliollsinC:t,1.21l1I1J./-IlIil'c.AsinglclIicolirh:dosc appcarcd 10 lead 10
an incrcascin unprolcclcdslrclchullcnds(p<0.OS)inC:I.. l.2DII P./.micc.incrcasillgt"rom
;tpproximatcly4.St07slrelchatlcndsona\'cragc.f\lil:rrcpcalcdnicOlincinjcclionsCa,I.1D11Il-
/·slillshowltlorcunprolcclcdslrclchattcnds.indicaling\\hcl1lheyare in thc open ann they are
cxploringmorClhal1lhc\Vf.Chronicallylhrcccompmisons\\crcsignificant (Ca.. I.2DHP-/· CC
ande .WTandCa\I.2DIIP./-NifcdipinJ.Ca"I.2D1IIJ./.andWTCIN)asthc)sho\\cdp-
values of less than 0.05. Chronic nicoline appears 10 increase unprolected stretch ~ltIends in
CI"I.2DI-IP-/-bul not WTmicc.whereas\\henCa"IJ is blocked wilhthcLTCCantagonisl
anxicly(lcssproICCIl".-dslrClch'llIends).howewrsimplyblockingCa.I.] ";IS notable 10 pre\cnt
Figun.' 9: r\ sin:,:le dose ur nil'olinc Il'l! III Ca, 1.2DIII'-I- lllil'c di.~pla)'ill~:' hi~her
unprOICl'ICdhcalidillr:ltclh;lI1WTlllicc.Nicotincappcarstoim:n:aSi: unprutcclcJ head dips
inbolhWTandCa,I.2DIIP./-.howcvcrniredipini:\\aSnOlabli:todccri::lscthisdlcctin
Cavl.2D1IP-/-micc.\\hcri:asiIUidinWTmicc(p<O.05).rhcrcwasllosignilic:llltdilTcrcncc
among the singlt: dose trcatt.-d Ca, 1.2DI-IP-/-groups (p>O.05). Then: \\usno signilicam:cscl."ll
IhroughANOVf\'sort-lcSlinlhercpeatcdtrcatment(chronic)groupslorWTandCav l.2DIIP--
Figurclll:l)mlt·ctcdlll'addipsarcderreasctlinWTlllieel,·call.'dwith nifedipinc, which
has thc opposite effcct on Ca,,1.2DIIP mice. WT Jlircdipin~ treated micl.: showl.:d a significant
dil1erenccfromthenicotinetremedmice(p<O.05).s!lowingniledipinedccreasl.:sprotl.:ctedhcad
dips. Ther~ \Vas signilicance sl.:t:n bt:twc~n niledipint: treated WT and Cav l.2DIIP./-micc
showing niledipine rcaclsdiflcrcntly in each mouse grollp. howe wrthl.:rcwasllosignilicant
dinl:rellC~ found between the three Cav l.2DHP-I- acute mouse groups. showing neither nicotinl.:





Uponc....aminingnifcdipinc·sctlCtISOn bolh mOliSC groups throllgh 1-1cSI:ll1donc-\\ay
A OVA analysis. nifcdipinehad noclleclonCa•. 1.2D1W·/-mice(Ca,,1.1D1IP.I.CINI07.-W!
10.07. NitCdipin 90.JJ:t11.22)repcaiedIYlrcalcdwilhnieolincnndilalsodidnotpn:",:nl
n:pcalcdnicotinc·s:mxiolyticefTectsinWTmice. In Figurc 12nifcdipinclrc:lIcdWTmolisc
opcnaml limc showed signilicance whcn WT mice lrealed wilh nicolinc nndlhoscprclrcalcd
wilhnif\..'dipinclnicolincwerccompared«WTC (n=9) l52.46:t 11.16. ifcdipinc!N(n=7)
261.64 :t 41 .60».llo\\cVer.llnlikcinBialaelal.(2006).nifedipine did not prcycnl anxiolYlic
c11ccts in WTmice. Nifcdipincacluallyappcarcdlo incrcascopcn ann Ii me.indicalinga
dl.'Crcaseinanxil:lybyhavingbolhcalciumslIbtypcsblockcd.ThcrewasnoditTerencesecnin
cOllclusionas WTnifcdipinc Ircalcd mice had un incrcaseinopcn arm Clllrics, coinciding wilb
Iheincrcascdopcl111rm limc. showing locomoliol1 was not impaircd bynili.:dipinc.with
nifedipinetreatedWTmicchavinganincrcaseof50%inopennrmclllrics.whencomparcdlo
WTnicolinclrC:llcd micc. Closed arm clltrics mirrol'l:d open arrn CI lIriesinWTmiccprctn:atcd
wilh nilcdipinc. as they showed a decrease in closed arm time as colllparcdlonicotinctrcated
Illice. and comp,lred to Ca~ 1.2DIIP·/· nifcdipinc treated mice (n= I0) (t-tcst p<O.05)
nifedipinc (realed mice (ANOVA and I-test p<0.05). showing Ca~1.2DIII'-I- mice had more
unprott.'<.:lcdstrctchancnds.Thisonccagainshowcdthatahhough lhcydid not spend morctimc
inthcopcnarms.thcrc!orenolindicatingdccrcasedanxictyinCa\1.2DIW-I· mice. thc) did
showlllon.:c.'\plnralioll.llo\\cvcr.\\hcnslatisticalanal)sis\\:\srllnhct\\cCl111kulim:anti
nili:dipinctrcatctllllollscgrollpstherew:\snomajordilli:renccwithinthcstrains(ANOVA
p>O.05). In protcclCd strctehancnds(FigurcS). WTnifctlipinctf'Catco miccsho\\cd a




nifedipincprctrC;:lICd miec. and WTnifedipinelrealcd mice also sho\\'cdasignilicmlllylo\\Cf
pcrccntagecompan;.'d loCa¥I.2DI-IP·/-micc (AI OVA p-vaille <0.05). showing nifedipine does
Opcnarmlimeremainslhcmainwayofdistingllishing<Ulxictylcvcls.\Vhichindoesappcar
to indic3te thaI nifcdipinedecreasesanxiety following blockadcorbothLTCCsubtypcsinWT
mice recciving n:pcatcd nicotine injcctions. but dOt:s not afTect Ca~ 1.20111}·/· mice whcn only
nieol inl: tre~lll."d grou ps. showi ng that the mOllse groups apJ'l."ar 10 reae I 10 nieol iIle al d i tlen:nt
limcpoinls.oncrollowingasingledose(Ca,I.1DIIP-I-)andWTIoIl0\\ingrcpc3It:dnicOIinc
Chronic Nicotine's Effect on Open Arm Time in WTandCa",1.2DHP-/-
Abbreviations: C/C(ControI/Colllrol), CIN (ControI/Nieotinc)
Figure 12: WTnifcllipinclrc:llcdmil'ch:I\'cincrl':ls..·t1uj)l'llannlillll'J'nllowillgn'pl':II"'l!
hUI 1101 following:lsillglcdoscofnicotin ..·.Follo\\ingnsinglt:doSl:ofsaJilll:Ornicotint:llo
signilicnncc was sccn bet\WCll niledipinc trentcd and nun-trt::Ht:d mice grOllps. or among
gcnOIYIXS(P>O.05). Followingrepcntcd nicOlinc Irt.·allllcni there wnsnn incrcnsc in open arm
lime in nifcdipinc prclrcnled WT mice (p<O.05). bUI 1101 sct:n inCa. 1.2D111)·/· micc (p>O.05)
WTnitf..'dipinClrcatcdmiccspent261%ascomparcdtotOO%illthcopcnarm:lIldcompart:dlo
Nifedipine's Effect on Open Arm TIme in WT and Call1.2DHP·/· mice
I
Fil-tureI3:WTnircJipineln::lteJllliCl'show:lIlincre:lseinopl'narlllcniricsrollowinl-t






Nifedipine'sAcute and Chronic Effect on Open Arm Entries in WTand
Cavl.2DHP-f- ice
J.6.Ca,.1.20J-IP-I-orCa,,1.3-I-gcllot'ypcsshowcd 110 initial bias in thcCPP
panHligmincolltrolmi(.·c.
1\11 micl: wac fUn through thcsamcCPP. under Ihl: same ligJlIingand sollndconditiotlsas
dcscribcd in the rnclhods Seclion 2.4.2. Twoscparalc WTconlrolswcrerllll.oncwilhani.p
PEG(vchir.:Je)illjcclionandoncwilhout;lbcCayI.2DJ-lP_I_rnicewcrcrllllwithcilhcrucolltroJ




uWTcontrolwithPEG(n=6)-59.3±54.09scconds.Thei.p.injcctionofPEG appearcd to raise
theaveragc limespcnt in a certain chamber wilhin theCPP. butthcre was no significant
dirrt:rencesecnamong PEG injccted and notl-injectcd mice (ANOVA and t-ICSt p>O.05). Two-
wayANOVAswcrenltlforaligroupsandshowcdp-valucsofgrcaterthan 0.05. confirming no
dillcrcnccbctwcencontrolgroups.rcgardlessot'whcthertheyrcccivedan i.p. injection
3.7. Nicotine place preference was established in \,yT,Cay I.2DI-IP-I-:ind
EachmollsegrollpshowedastrongpJaceprcfcrcncefornicotineatadoseofO.5lllglkg
(Figure J4). PrcviollsrcporlsofO.5mglkginitiatingaplaccprcfercnccJcd rnetodccidcon this
dOS:lge(Gr;lbus. ~t:Jrlinelal. 2006: KOlil. i\larlinclal. 2007).cspeciall) ancrEI'M resulls
sho\\cddiITcn:lHn:sulls;lllhcnicOlincooscorO.llIlglkg.rixedfaClorANOVAs\\creruntor
atlgroups and Ihep·"illllt:slorCa.,1.3·/·.Ca,I.1DIII)-/-<lno\VTconlrol\'Crsusnicolincgroups





associalcdsidcspendillg99.181.±37sccondsmorconlhcdmglrcall'<1side o\'cr Ihc saline
Ircalcdside.rinilllyCa,1.2DI-IP·/·controlmice(n=7)showcdllOPlaccprcfcrence(-23.±19.298
sec). whilc nicolinc (n=6)lrealcd mice showcd a strollg prcfercncc for nicoline (I 18.166.±
TheCav l.2DI-IP-/-miccshowcdlheslrongestprcfcrcnccwilhap.\'alucofO.008anda
prcfcrellCClimcofl18 seconds. which is approximatcly 20 sccondsmorclhan\VTandCa.l.3-/-
micc.Thcscrcsultsrc\'calcdnicotinc'srcwardingabililylhrough indllcing a slrong place
J.8.Prctrc:ltl11clltwilhnifcdipillcprc\'clllcdnicOlincplaccprcfcn'l1ccin
Nifedipinc.unLTCCantagonist.\\asadministcredi.p.15minpriorlonicolincorconlrol
injl..'Ction s.c.. \\ hich foIlO\\t:d previous \\ork using mice in the CI)P (Grabus. ~lartin ct ~ll. 2006)
FigureI5sho\\sCa,,1.2DIIP·I-and\VTmicelhalwerctrcatc-d\\ithnifcdipinc\\-hichmados.1.gc
01'10 mglkghad no locomolor dTects on the mice. Ca,I.J-I· mice were cxduded.aslhisdos.'lgc
Ci.lvl.2channclsinCavl.J.I-micc.wilhnifcdipine.wouldabolishallyprefcrcnccsecninlhcsc
humanereasonsandalsobecauscanydalacolll..'CtedwOllldbccxlrcllldyskewcd
InbolhCay l.2D1-IP-I-andWTgroupsprctrc3Icdwilhnifcdipinc.place prcfcrcncc was
Figure 15 shows Cavl.2DIIP·/·nicotillc versus nif~dipine groups anti their difl\:retlces
havca p.valllc less thall 0.05, indicating that the nil:otine prd~n:ncc is abolished by nifcdipinc





nicotine and nilcdipinetrelltcdmicc(p<0.05),and howlhcrcwasnosignilicantdillcrcnccscen
bc\ween control and lheir respective nifcdipinc treated mice(1'>0.05)
Fi:':Ufl' I.J: Niculinc place p"cferenn' was seen ill :llllh"ce :,:elltll)'pcs Hf min' tesled. Alllllr~~
mousc gl..'IlOI)'pI..'S trcat~d \\ith nicotinc sho\\l..'d signilieatn plJCC prdcrcllcl..' for nicutilll..' (p<O.05)
PEG i.p. injcctiondidnol intcrlcrc with the acquisition of the nicotinl..' plncc prclcrcnce
CJ.I.2D1IP./.miccs!lowcdlheslrongcslnicotincplaceprclcrl..'llccofI18S1..'conds.\\hilcCJ.l.3
Fi:.:urc 15: Nirl'llipillchlo".'kt.'d nicutine's abilit)' to c:wsc a piaccprcl'crl'llccinWT:ulll




groups, sho\\inga slrongplacc preference for nicotine. This prcfcrencc wa5abolished by
nifcdipincin\VTnndCa•. 1.2DIIP-/-mice(p<0.05).asshownrromthe prelcrcnce in bolh
subtypes (C<I, 1.2DHP-/- C \\ ilh PEG: 118 sec 10 Ca~ 1.201IP-/- C/ \\ ilh Niredipine: 30 St.--C:
Ch"plcr~
Behavioral t~sting is highly dcpcmknt on the cxpcrimcllter's cyc lor detail and lor
decay. mcaningthc morc miccare placcd in the maze, the Icssrcliable the results arc. Early
reports l"rom Pcllowct al. (1985)and Lislcr (1985) showcd that multi plecmricsintheEPMdid
not slatisticallyskcwopenann behavior {pellow. Chopin etaJ.1985; Lister 1(87)
behavioral reslllts may be tainlcd following multiple entries. showingudecrcasc ill opcn arm
Along \\itll Ihese studics that might argllc against using mif.:c morc than oncc in EP~I
ti:sting. thc protocol our EPM trial was bascd on tt:sh..·d lllict: ill IWOI rials.follov.ingbolhsinglt:
andn:peah.:d nicotine injections. This protocol hasnotpn:viollslyn:porlcdan)skc\\ingofn:slllts
13udzynska2006). 13inlaonlyuscd WT mice and not Ihctransgcnic micc \\cllscd.\\hichmaybc
4.1.2.J)rug41ssocialionliming
lollo\\'ingn:pcatcd nicolinc injcctiollS(EPM) (Lc Full ami (juldl}\.'rgl005;Grublls.~brlinclal
WithinlhcEPMparadigm.llsliclal.(1007)dl·scribcdthcircxpcrimen1 lIsingun UClIlC
nicolincdoscofO.25mglkg.cithcr30orI50minbclorcplacinganimuIs into the EPM. rile)
found Ihnt Ihe30min lime point prodllcC'd an aClitc nicotincanxiogcnicdTeCI.\\hcn:aslhclatcr
timcpointdidnol(lIsu.Chcncta1.2007).Anolhcrgroup.alsoill\cstigating nicotinc's dTc..'Cls
\\ithin the EPM found that nicotine injcctcdatl\\oditkn:ntdoses showcdaclitcanxiogcnic
cl1i:clsat7minbulnotat30minanernicotincinjcctiol1{Zarrindasl.lloma)OUnclaI.2000)
Acutc nicotinc was also shown 10 beanxiogenic5 min ancrinjcction;howc\'cr.follo\\inga30
min waittimc. rnlS failcd to bt.."Comeconditioned 10 nicotine and thcreforc noanxiogcnic results
vital and so we followcd Bialaand Budzynska(2006).whollscdawaiItimeof5minpost·
nicotine injeclion to place mice into the EPM. Since WT and Ca~I.2DI-IP~/~ initially showed a
\\ilhin th~ mall.: lollowing drug administration (Grablls. r..l:lrtin ct ;.1. 2006). E"1:1l \\llh var~ing
dOS<lgcs ill\'~sligators still place the lcst subjects into the chamber iml11ediately tollo\\ing drug
injcclions 10 optimizc lllcl11oryassociation bdwccn Ihc chambcr and thcdrug(Fattorc.Spanoel
aI.2009).lnourcxpcrimcllts.weoriginallyinjcCh:dmicco\'crlhclr hOlllc cages. and lhcn plnccd
thcninIOlhcCPPch:lInbl:r.llowc\'er.wefollndlhalmicc\\crCnOldispla)ingaslrongnicolinc
ThistcchnicaldClail pro\'t..'d to be vilal forCPP.asilmadclhcdincrcllcc bct\\ccn showing a
4.1.3. Dosage
rhisdo~ornil:utinc\\asdllJsl:llasit\\aSllSCdrcpl':llCdlyil1thl:\\nrk rrom Biala's
laboratory \\ith similar anxiogcllic rcslIlts (Biala and Kruk2009: Bialu. Krukl:tal. 2009). Biala
tcstednicutinc'sdoscdTectstcslingmicc5andJOminancrl\\odoscsofnicutinl:(0.landO.5
mglkg).\\ithonlythcO.lmglkgdoscprol.lllcinganxiogenicdl\:ctsinWTmicc.indic:.llinglhata
highcrdosc ofnicoline docs not increase negative aClltr: dlcctsubst:rvcd \\itbin the EP~I (Di;lla
mglkg.causedanxiogcnicnicotinedTl'Cts:howc\'cr.ineachcxpcrimCllt.thcirprocedurc"aried
2000; Ilsll.ChcnctaI.2007). BnlcrioCI al. (2005) found lhat a lowdosc ofnicotine(0.05mglkg)
(lJalcrio. ASOr:1 al. 2005). Our results agrccd \\ith lJialacl al. (2006) rcsultsrcgardinganxiol)'tic
In bOlh EPi\·! :lIld CPI) paradigms nill:dipinc \\as lIs~d tu irl\~stig:lI~ \\h~lh~r blol.:king
on~ or both L ITC subtypes \\Quld d~cr~as~ :IIlXicly aClltdy or prc\'cnlnicolin~plac~ prclcrclll:c
from occurring. rile dose of niledipinc used in EP~llcsling was based upon Biala ~t al. (1006).
ill\\hichthcyinvcsligatcdthccfTcctsofLTCCant:lgonists\\itharangcofdoscs.suchaslO
E\idcncchasshownlhaILTCCCa"I.3channdisincomplctdyblockcdbyDIII)
\\hich are completely blocked. Xuct al. (2001) in\'cstigalcd this conclusion and reported thai
with typical LTCC DI-1Jl anlagonists. at lypical conCclllrations. approximatclySOOloofpenk
Ca"I.3alchnnnclclirrenlswcrenolblockcd.illdic3tillglhallhcydonot have as high an allinity
for OHP modulmors as Ca,,1.2 channels (Xu and Lipscombe 2001). ifcdipinc was not ~fTcclive
in prcvcntinganxiogcnic or anxiolytic afTects seen aculelyorc hronicallyill the EPM:howe\'cr.
Ihismuybc1cssofadosagcproblemandmorebccallscoffaclorsanribLLledtothcgcnclic
was again b..1scdllponancxpcrimenl bythc Bialagroup. in \\hichlhcyuscdS.lOand20mglkg
itllhc EP~1. In both WT ami Ca,,1.1DIIP-I-.nil\.-dipinc givcn i.p.;11 10 l1Ig1kg curnpklcly
IhanDllfV2Illicl.:.lhl.:irl.:ognilivcandbchn\iuralful1l.:1iullSarC110rllwI and lhl'rcforc provide a
rhrollghbrccdingand handlinglhcm tor lhc Icnglh of the prcscnl SIUOy.I didnOliccslighl
·t2.1. L-I)'PCC:llt chanllclsuhlypcCa,I.J-I-:Il1dClI,1.2DIIP-I-miccboIh
displayed nicofincpl:lccprcfcrcllcc,which nifcdipincprcfrcatlllcnfwas





lorcbraillllcurollS (Etheredge. ~l11rchison ct al. 2007). \\e suspect Illnt when Cnv l.3 is rJdctcJ
frolll thegcnmm: initially Ca,I.2 is nblc tocompcnsatc tor this ch:lllllclinlhcll1csolill1bic
S)'sIClll.allowingnicotincrr.:wnrdloslilloccur.Ca,I.2areacti\:ued'lt a higher \oltagc than
Ca,IJ.mr::lI\ingthey\\OllldllotuctivatcatlhesumcspccdusC:I,I.3: howcvcr. they rcmuin
funclionally ablc 10 inilialC the calcium inllllx necessary toacti v:llcl11ulliplecascadcsandbursl
fhr.:rcfore.wcbclicvClhal\\hr.:nbothLTCCsubt)pcsarcprcscntwithinthe brain. Ca,I.3
plays 3 morcprominent rolcthan Ca,I.2in initialinglhcinlcmnl0Acrgiccnscades lending loa
Illullitlldeofolltcomcs.includingphosphorylationand burst liring.Thisundcrstandingor
subtypcrolcsw<lsagaill rurthcrslipportcdwhr:1l we blocked the LTCCsubtypcCu,,1.3inthe
CavI.2D111)-/-mice.asplaceprefcrcncerornicotincwascompletc1y abolished <lnd was rctllmed
to control lcvcls. l'laeeprcrcrcncc was also diminishcd to baseline Icvcls(approximatcly55/45
timcspcntbctwecn the two chambers) in WT mice tre,ltcd withnifcdi pinc.Soaficrsecingboth
outcomes in WT and Ca~1.2DJ-IP-/·mice, it strongly indicates thut LTCC subtype Ca~1.3 has a
blocking Ca~ 1.3 nnd only Ca~ 1.3. in Cav1.201IP-/- mice. leaves mice who showed place
preli:rellce for nicotine displaying no place preference
Thercl.lppcnrs to be two scenarios of how LTCCc<lnildapt.onc in which the gem: is
complctdydclctcdandthcothcrinwhichbothareprcscntbutonecouldbcdamagedornot
functioning. \\ hich is similar to what we demonstrated with tht: CUv1.201IP~/- mice. In humans it
isextrcmclyrarclohavcadclicicncyinLTCCslIbtypcCavl.];thcrcrorc. it is critical to bc able
lo\V~r activation ~Il~rgy and fast kinetics. has a critic.1I rull: in acquiring nicoline reward. as sel,'n
in Ihe CPP paradigm. We are not assliming thai Ca~ 1.2 docs nO! h:IVC a role in Ihe dop:unincrgic
subullitshavcahighcractivaliollvollagc.Ca,I.3prcsumablybccomcsaclivaloobeforcCa,I.2
walltcdloblockthcCa,.I.2channelsinlhcCa,I.3-I-micctofurlhcrprovcLTCCsimportanlin
is pn:sumed 10 underpin the addiclivc dli:cts of the Il\l.'soli lllbic DA p~ltl1\\ay acli Hit ion. ;\ Iso
4.2.2. C.I,.1.2DI-IP-I-:llld \VTmiccdisplayanxiolyliccffcctsofnicolincinlhc
EI>Mbutatdiffcrcnttimcpoints.
lllll.:X(X"ctl."d. as aClite nicolinc Irc~ltml."nt have bl."l.:ll shO\\'1l to bt: anxiogl."llic ill micl.:. \\ hl.:rl."as the
CI,I.2DIIP-/-micccknrlyshO\\l.:dudecreasc. nOI:lll incn.:asl.: in allxil.:ty.Endogl.:llolisDIIP
anlngonistsarc nota novd idea: howcvcr il may providcn rl.::lson as 10 \\hy C:l,1.2DIlP-/· mice
sho\\l.:d an incrc:1Sl.: in anxiely. Arnchidonic :lInidl.: is found l.:ndogl.:l\ousl) \\ ilhin thl.: brain ~lJ1d
hasoccnsho\\nIO:lCI<ls<U1L'ndogL'llollscalciumchunnclantagonistforlhcIA·D1lll bindingsitL'
may indeed have a rolc in caleilllll eurrenl regulution and they also I."xpl aincdthalbolhhcparin
andG protcinscan nailirally modify DHP binding or Lchanncl currcnts(Johnson.llealdelal
1993). In our modd C<i,1.2DJ-IP-/-donot have a funclioning DIIPsilC lorCuvl.2channds.
lhcreforconlyCa,I.3LTCCswouldbcaITecledbylhecndogcnollS<llltagonisls.Thcreforcin\VT
mice these cndogcnous DHP anlagonisls have Ihe ability to work 0nbothLTCCssublypes.
polcntiallyealisingananxiogenicclTectinthcsemiccwithinlhcEPM. or simply cancL'lingollt
any unxiolytic dlcct, which is whal WCS<lW in thc EPM as lhcrl.: was nomajordilTcrencesccn




nicotincsmok..:rswhocxperienceanxiolyliceflectsnslongas:lrCIh..:y smoking chronicalty and
4.2.3. Repented nicotine's anxiolytic effect was not blocked bynifcd ipine
prctrcOltment in WT mice in the EPM.
fully dissolve nifedipinc and caused pain and discomfort ill our mice. Wc ~nding lip (r)ing Ollt a
fewsolutions.dillcringinconccntrntionsand fillally scllied on usingaPEGI2%J)i\ISOsolulion
described in lh~ mel hods. which did not cause any p~lin or discomfort 10 our mice and dissolved
nifedipincfully. We acknowledge lhal thisdivcrgencc from Oiala 's proccdure may produce
dilTcrcnccs in resuhs because if the nifedipincthey llscd did not full ydissolvc.thcymayhavc
I:ndt:dupwilhonemOlisereceivingtoomlichnifcdipinc<lndullothcrreceiving too little or with
Dillcring reslllts seen from the EPM may be bccallsc it is 1101 a pcrfcct testfordirectly
manysciclltistslmveillvcstigatcdthcconncctionbdWl..'CllvoltagC(kpl..'ndclllCalcilllllchanncls
C:l.I.2111aybcmorcvitaI.Whc:nbothLTCCswcrcblockc:dinWTmicethcre\\asim;rc:ascd
opc:narm time. showing un c:xtcnsive decrease in:mxic:ty. WT mice disp1:lyeddecrcasedanxidy
or:1l1 increase in anxiolylic elTects followingnilroipine. indicating that pc:rhapsblockillg LrCCs
prcvcntsfcarmc:moryfrombeingfomlcd.C311singthcmollsctobch:ssanxiolls\\henCa.l.2is
Oyusing the nicotine reward paradigm tostlldy LTCCs. \\C aimed toin vestigatehow
blocking LTCCs wOllldafTcct nicotine reward. givillgus insight inlo nicotine addiction. We used
LTCC Ca~1.2DIII}-!- mice to investigate the role orCa l 1.3 in stress responses \\ithin the nicotine
paradigm in the EPM. However. we did not sec the decrease inopcn arm lime (increase in stress)
rollowingpretreatmentwith nifcdipine, as was originally shown in WTmicefromthel3ialactal
(2006) cxpcrimcllts (Biala and Ellldzynska2006). This may have bccn caused by blocking
Ca~ 1.2. within the amygdala. along with the YTA and not allowing thc mice to consolidalc the
fear or stress rcsponsc wilb lbe drllg given inilially(nicolinc orsalinc)
In hindsight. ifwecollld haveinfuscd thcnifedipincJirectlyintothcYT/\'wcCOllld
have been certain Ibat it was primarily affecting thc targctcd arca. I lowe vcr. this technique raises
iSSllCswithpropcrcannulainserlion,undwithtryingtominimalizeanystructurald:Ill1<lgcwitb
As mentioned pre"iously there are cndogenous an13gonists thatcanafTcct the DIIP
binding site in LTCCsnnd along with thelll there nrc illso cndogenousagonists.sllchas
~ndog~nolls opioids. which call aid in addiction formation and thl: positi\~ s)mptmns. associ:ll~d
\\ith nicotine addiction. such as It:ssanxit:ty. f\lthoughl:ndogt:llotisupioidsrl.:scmbkplanl-baSl:d
opioids. lhcy arc produccd within the bodyalld wcrc firstdiscovcrt:d inthI:1970s(Trigo.rvlnrlin-
Gnrciaclnl.:I'olllcrll.:nllI998).Endogenousopioidsnrcknownlohaw\\idcsprendclli:cts
\\ithinnolonlythl.:CSbulthroughoulthcpcriphcr..lls)Sh:ll1SandatTcclconncctionsbet\\ccn
the VTA. thcam)gdalaand PFClhntnrcvital tOlhcl.:lllotional and bchmior..llrcinforcclllcniof
addictions.ll1cinvol\'cmclltofopioidsinsmokingcontinuutionwnsfirslpublishcdbyKarTas
and Kanc in 1980. in which they invcstigatcd lheuscoflhcopioid antagonislnaloxonc10
dccrcasc cigarcllc sll10killg (Knrras and Kane 1980). Inthc VTA.cndogcnOliS cnkcphatins are




I-miccwcrcllscdtoinvcstigalctherolcofthc LTCCs. bllt with morctimc.lwollldhavctcstcd
both sllbtypcs in the EPM and tested dilTcrcntdoscsofDllP antagon isis to gct the prccise dose at





".3.2. To siudy Ca v I.3-1- micc in both thc EI)M :Ind thc CPP to sec if Ca\ I.3 is
l11orc\'italinnicOlincaddiction,o\'crall:lddictionandthclllcSOlimbic
VTAdop:'lInincrgicpalhway
....3.3. To complele immullohislochemislry Oil both LTCC suhtypt's to
detcrmine lhcirllislribulion within VTAdop~lIl1incrgicncurons
Topnndbollombnndhctcrozygous(+I-) 390. 475 b.p
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